Enhance MD vs Ro.co: Semaglutide, Tirzepatide, Wegovy Pill

Quick verdict: Enhance MD is strongest for low introductory pricing and access to both compounded semaglutide and tirzepatide, while Ro.co stands out for access to the FDA-approved Wegovy pill and an injection-free option.

Start with Enhance MD pricing

Enhance MD vs Ro.co: head-to-head summary

Enhance MD advertises semaglutide from $49 and tirzepatide from $99 for the first month with flat-rate pricing that stays the same at every dose. Ro.co advertises you can get started online for just $39 and offers the Wegovy pill, an FDA-approved oral GLP-1. Treatment on both platforms is subject to licensed clinician review. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.

Key differences to weigh

1) Starting price and entry cost

Enhance MD lists semaglutide from $49 and tirzepatide from $99 for the first month. Ro.co promotes a “Get Started Online for Just $39” entry point. Both providers use direct-pay entry pricing; ongoing costs vary by platform and plan and are disclosed differently.

See Ro.co start for $39

2) Medication type and regulatory status

Enhance MD offers compounded semaglutide and compounded tirzepatide on one platform. The provider notes compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Ro.co offers the Wegovy pill, described as the first FDA-approved oral GLP-1 weight loss medication; Ro.co emphasizes this is a finished, FDA-evaluated product rather than a compounded injectable.

Explore Enhance MD compound options

3) Pricing model and predictability

Enhance MD markets flat-rate pricing that remains the same at every dose with no escalation during titration, which the provider frames as easier budgeting for patients who expect dose increases. Ro.co states it discloses pricing before consultation and highlights no hidden fees; however, Ro.co also notes branded medications typically cost more than compounded alternatives.

4) Best use cases and patient priorities

If your priority is lowest first-month cost for either compound and access to both semaglutide and tirzepatide compounded on one platform, Enhance MD is presented as the budget-minded multi-option choice. If you prioritize an FDA-approved oral medication and want an injection-free route with finished-product regulatory clarity, Ro.co is presented as the better fit.

Pros and cons compared

Enhance MD: Pros include the lowest first-month prices for both compounds listed, flat-rate pricing with no escalation, both semaglutide and tirzepatide on one platform, and a claimed 10,000+ patients treated. Cons noted by the provider include that the $49/$99 rates are first-month introductory prices and that medications are compounded rather than branded finished products.

Ro.co: Pros include offering the Wegovy pill as an FDA-approved oral GLP-1, a $39 start option, and pricing disclosure before consultation. Cons noted include that branded, FDA-approved medications can cost significantly more than compounded alternatives and ongoing pricing varies by plan.

Final thoughts on Enhance MD vs Ro.co

Enhance MD vs Ro.co comes down to whether you prioritize lower introductory costs and flat-rate compounded options or the regulatory clarity and injection-free convenience of an FDA-approved oral medication. Both require a licensed clinician to determine medical appropriateness and both note compounded medications are not FDA-approved where applicable.

Review Ro.co Wegovy pill option

Choose based on these facts

• Choose Enhance MD if you want semaglutide from $49 or tirzepatide from $99 first month, prefer a flat-rate pricing model, and are willing to use compounded medications subject to clinician review.
• Choose Ro.co if you want access to the FDA-approved Wegovy pill and prefer an oral, finished medication with pricing disclosed before consultation.

Start with Enhance MD now